INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,558 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
100 sh
Dec 30, 2025Dec 31, 2025
Page 1556 of 1814
← PrevNext →
traded Dec 30, 2025
+1d
SEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$27K
2,605 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,395 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,605 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$1,292
124 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
2,500 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
3,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$50K
2,500 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
HT
Hall John TDirector, Chief Executive Officer
INTAIntapp, Inc.
Option exercise · 10b5-1 plan
M—
8,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
LA
Le-Quoc AlexisDirector, Chief Technology Officer
DDOGDatadog, Inc.
Derivative conversion · 10b5-1 plan
C—
32.4K sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Dec 29, 2025Dec 31, 2025
traded Dec 29, 2025
+2dSEC Form 4

Evidence

0
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$25K
2,395 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC Form 4

Evidence

56
KE
Kao John EDirector, Chief Executive Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$10.71M
572.4K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

55
FH
Frank Edward H.Director
RKLBRocket Lab Corp
Open-market sale
SELL$193K
2,500 sh
Dec 23, 2025Dec 30, 2025
traded Dec 23, 2025
+7dSEC Form 4

Evidence

49
SL
Scavo Robert L.Chief Information Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$1.23M
65.7K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

49
TA
Tpg Gp A, Llc10% Owner
NANATPG Twin Brook Capital Income Fund
Open-market purchase
BUY$100.00M
3.98M sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

49
MC
Maroney Dawn ChristinePresident
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$4.99M
266.6K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

42
JJ
Joyce Christopher JChief Legal and Admin. Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$286K
15.3K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

42
BD
Brazeal Mark DavidChief Legal & Corp Affairs Ofc
AVGOBroadcom Inc.
Open-market sale
SELL$9.13M
25.9K sh
Dec 26, 2025Dec 30, 2025
traded Dec 26, 2025
+4dSEC Form 4

Evidence

42
MC
Maroney Dawn ChristinePresident
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$300K
15.5K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

42
KE
Kao John EDirector, Chief Executive Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$644K
33.2K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

41
JW
Jones Jack W.Director, President & CEO
FKYSFIRST KEYSTONE CORP
Open-market purchase
BUY$26K
1,400 sh
Dec 30, 2025Dec 30, 2025
traded Dec 30, 2025
+0dSEC Form 4

Evidence

40
GA
Georgiadis AnthonyDirector, PRESIDENT
GTIIGTBIFGreen Thumb Industries Inc.
Open-market sale
SELL$2.00M
2,500 sh
Dec 28, 2025Dec 30, 2025
traded Dec 28, 2025
+2dSEC Form 4

Evidence

39
SL
Scavo Robert L.Chief Information Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$74K
3,813 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

39
KH
Kim HyongChief Medical Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$224K
12.0K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

36
LC
Lucree Lorne ChristopherDirector
BSLKBolt Projects Holdings, Inc.
Grant or award
A—
750 sh
Aug 29, 2025Dec 30, 2025
traded Aug 29, 2025
+123dSEC Form 4

Evidence

36
KB
Kovler BenjaminDirector, CHAIRMAN & CEO, 10% Owner
GTIIGTBIFGreen Thumb Industries Inc.
Open-market sale
SELL$2.00M
2,500 sh
Dec 28, 2025Dec 30, 2025
traded Dec 28, 2025
+2dSEC Form 4

Evidence

36
KH
Kim HyongChief Medical Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$13K
696 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

36
ZG
Zauder GailDirector
BSLKBolt Projects Holdings, Inc.
Grant or award
A—
750 sh
Aug 29, 2025Dec 30, 2025
traded Aug 29, 2025
+123dSEC Form 4

Evidence

36
JJ
Joyce Christopher JChief Legal and Admin. Officer
ALHCAlignment Healthcare, Inc.
Open-market sale
SELL$17K
888 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence

35
PM
Patel Ketan MPresident, Personal Systems
HPQHP INC
Open-market sale
SELL$773K
33.3K sh
Dec 26, 2025Dec 30, 2025
traded Dec 26, 2025
+4dSEC Form 4

Evidence

34
KB
Kravitz BretGENERAL COUNSEL AND SECRETARY
GTIIGTBIFGreen Thumb Industries Inc.
Open-market sale
SELL$58K
7,337 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC Form 4

Evidence